- On May 25, 2017
- 21st Century Cures, Infusion, Medicare, Reimbursement, Survey
A new survey from Innovatix is highlighting concerns home infusion providers have as the 21st Cures Act enters its fifth month. Under the law, which was signed by President Barack Obama in December 2016, the payment structure for infusion drugs under Medicare Part B changed from an average wholesale price to an average sales price.
- On November 28, 2016
Premier Inc. (NASDAQ: PINC), a leading healthcare improvement company, reached an agreement to acquire Innovatix, LLC and Essensa Ventures, LLC, two continuum of care group purchasing companies for $325 million. Premier currently owns a 50-percent interest in Innovatix. GNYHA Holdings LLC, an affiliate of the Greater New York Hospital Association (GNYHA), currently owns the other 50 percent of Innovatix and 100 percent of Essensa.
Innovatix, LLC, the nation’s leading non-acute care supply chain solutions company and group purchasing organization, has launched a new consulting service designed to support pharmacies in achieving recognition from various accrediting bodies, including URAC.
Non-acute healthcare facilities, K–12 schools, and a wide range of businesses have new resources to help them lower overhead costs and save money through group purchasing with the launch of www.innovatix.com, the new website of Innovatix, a leading group purchasing organization (GPO).
- On September 15, 2015
Pharmacies have a new tool to ensure the accuracy of prescription claims and obtain maximum reimbursement on each claim with today’s launch of Scriptmax™, a Web-based prescription claim support program and data analytics service created by Innovatix, LLC. Available to longterm care, home infusion, mail order, retail, and specialty pharmacies, Scriptmax is a one-stop shop, offering a comprehensive suite of pre-edit, post-edit, and reconciliation services, all accessible through a single convenient online portal: www.scriptmax.com.